The co-founder of Scion Life Sciences on coming out of stealth mode and the new $310 million venture fund announced this week

blonca9
Feb 9, 2024
1 min read

Aaron Kantoff describes Scion's mission and investment strategy, discusses co-founding RayzeBio, and shares his thoughts on the current state of biotech.

Recent Posts

See All

As federal funding for cancer research has been jeopardized at NIH and academia, Parker Institute for Cancer Immunotherapy is one private institution ready to step up and broaden its impact

Mount Sinai has embraced AI as a drug discovery tool by launching this month its new AI Small Molecule Drug Discovery Center - Professor Avner Schlessinger tells us why

Jones Healthcare & Technology Innovation Conference: Jones Research analysts Soumit Roy and Justin Walsh share their take on biotech and comment on companies they cover

The co-founder of Scion Life Sciences on coming out of stealth mode and the new $310 million venture fund announced this week

Recent Posts

Join the BiotechTV mailing list

Follow BiotechTV

Sponsors

Sponsor Spotlight